Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Since market close Friday, 11/30, AMBS has gained 178% (.0228 to .0634) in 15 trading days on 248 M volume. I'm sure we could all use a couple more of these in our portfolios...and the best is yet to come!
Golden Cross occurred late this past week.
Major news coming, and they will present at the OneMedForum in San Francisco 1/8/13.
Know what you own, and don't let anyone steal it away from you!
Very, very long AMBS
Since market close Friday, 11/30, AMBS has gained 178% (.0228 to .0634) in 15 trading days on 248 M volume. I'm sure we could all use a couple more of these in our portfolios...and the best is yet to come!
Golden Cross occurred late this past week.
Major news coming, and they will present at the OneMedForum in San Francisco 1/8/13.
Know what you own, and don't let anyone steal it away from you!
Very, very long AMBS
As they have not yet completed the CUSIP change here in the US, why do you think they would complete it "legally" on the Boerse when they didn't want or authorize to be there to begin with?
If the Boerse is showing the updated CUSIP info, that in itself is proof that the Boerse is a useless entity and lying about its activities. Lies are easy to change constantly!
Very, very long AMBS
Initially posted by another poster Wednesday, 12/19:
"Either you believe in the company and its management and the tremendous potential that its patented MANF technology offers or you don't.
AMBS is the most undervalued bio-tech in the market.
Expecting to be above .07 by Friday and headed to .10."
Now, while we didn't quite make 7 by market close Friday, the question is, "In the 2 DAYS that have elapsed since that original post, what has changed?" The company continues on its growth path and the stock has continued upward (178% in 15 trading days).
Very, very long AMBS
Originally posted by another poster Wednesday, 12/19:
"The 'potential' discounted value of the patented MANF technology should have the company with a current market cap in the $50,000,000 range or about .25/share.
It's tremendously undervalued with substantial upside.
That is why I'm adding on the dips."
Now, the question is, "In the 2 DAYS that have elapsed since that original post, what has changed?" The company continues on its path and the stock has continued upward.
Very, very long AMBS
Since market close Friday, 11/30, AMBS has gained 178% (.0228 to .0634) in 15 trading days on 248 M volume. I'm sure we could all use a couple more of these in our portfolios...and the best is yet to come!
Golden Cross occurred late this past week.
Major news coming, and they will present at the OneMedForum in San Francisco 1/8/13.
Know what you own, and don't let anyone steal it away from you!
Very, very long AMBS
Since market close Friday, 11/30, AMBS has gained 178% (.0228 to .0634) in 15 trading days on 248 M volume. I'm sure we could all use a couple more of these in our portfolios...and the best is yet to come!
Know what you own, and don't let anyone steal it away from you!
Very, very long AMBS
My hat is off to you sir! It is a rarity for an honest ihub poster to "own up to making a mistake." Most blame anything and everything else or try to create fear (where minimal question exists) to cover their own misstep.
IMO, you will not be sorry getting back in AMBS at Monday's open. Worrying about a penny or two (or worse a fraction thereof) when buying down here is only a worry for "flippers and traders," and they will soon be left in AMBS' dust.
With the significant growth potential, quality of those involved and constantly demonstrated transparency, it's sad to think many may miss out.
Very, very long AMBS
If opinion on AMBS is what you are looking for, then this board has an abundance of that. It also contains an abundance of useful and quality verifiable information.
If you are open-minded, then read all posts from say 11/1/12 to today. Yes, it is a lot of reading, but quality DD is not supposed to be easy. When I consider spending my money, I don't believe there is too much DD that I can do in order to make the decision that I believe is right for me.
Part of your DD should also involve reading poster information not just their posts. You will certainly find many with "self-serving agendas," but you will also find many who committedly sit on one side of the fence or the other based on facts, PRs, emails and potential. Many sit on "which ever side the wind is blowing from."
From the following, "P.s. In italy a lot of people are waiting for shares increase -----> dilution (in this case share value 0,025??????)" it would appear you may have already made up your mind as to which side of the fence you wish to reside. Let's see what time reveals.
In any case, "Welcome" to the AMBS board!
Very, very long AMBS (and by that I mean years not hours, days, weeks or even months). Now you know which side of the fence on which I reside, but please make up your own mind based on your own DD and "agenda."
Originally posted Monday, 12/10 (pre-market)
"Of all the 1,000's of penny stocks that are currently being traded I can't find another one that has more potential upside than this one.
I don't see how anyone can pass on the opportunity to buy a few shares at the current price.
The comparative study results should draw additional substantial attention to the company from the market and new investors.
I'm expecting a very Merry Christmas and a very prosperous 2013 for all the company's shareholders."
Very, very long AMBS
Originally posted by another poster Wednesday, 12/19:
"The 'potential' discounted value of the patented MANF technology should have the company with a current market cap in the $50,000,000 range or about .25/share.
It's tremendously undervalued with substantial upside.
That is why I'm adding on the dips."
Now, the question is, "In the 2 DAYS that have elapsed since that original post, what has changed?" The company continues on its path and the stock has continued upward.
Very, very long AMBS
Initially posted by another poster Wednesday, 12/19:
"Either you believe in the company and its management and the tremendous potential that its patented MANF technology offers or you don't.
AMBS is the most undervalued bio-tech in the market.
Expecting to be above .07 by Friday and headed to .10."
Now, while we didn't quite make 7 by market close Friday, the question is, "In the 2 DAYS that have elapsed since that original post, what has changed?" The company continues on its path and the stock has continued upward.
Very, very long AMBS
Best $100 I ever spent...premium message boards with UNLIMITED ignores. My list is rather long because I detest stupidity and a lack of ethics or morals.
Very, very long AMBS
As stated on the RBCC board, that agreement has not be finalized. Smart companies gather as much interest (i.e., financing options) as they can then they select what they will actually execute. Besides RBCC money and terms are what would matter, not the reputation of RBCC.
Also, it is best not to talk in absolutes...everyone, all. You speak for yourself and certainly not for me and I would guess many more on this board and in this company.
.22 will be here before spring 2013.
Good bye!
Very, very long AMBS
Seriously doubt this JV will come to fruition. RBCC is not in the same league with AMB*. Speaking of lack of credibility...
The following was posted 12/9:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=82275531
CUSIP change anticipated to be completed before year end, per Gerald.
Very, very long AMBS
AMBS
Dr. Garrick joins Amarantus with over 20 years of pharmaceutical and biotechnology experience. He currently serves as the Chief Operating Officer at Bridge Clinical Research and is President of the American Medical Association Foundation.
They will not constantly update info published previously just because timeframe has shifted.
Right from website and PR.
You are asking two different questions in your post. He was the immediate past president of the AMA Foundation not the AMA.
http://www.ama-assn.org/ama/pub/about-ama/ama-foundation/about-us/the-ama-foundation-board-directors.page?
Very, very long AMBS
The OTC Tier System (from OTC Markets website)
All OTC securities are assigned a market tier based on their reporting method (SEC Reporting, Alternative Reporting Standard) and disclosure category – Current, Limited or No Information. Securities on OTCQX, the highest tier of the OTC market, are required to have Current disclosure and meet minimum financial qualifications. Securities in OTCQB tier must be SEC, Bank or Insurance reporting and must be Current in their disclosure.
Very, very long AMBS
It would prove beneficial if individuals citing press releases that are not current releases also include the date of original release.
Very, very long AMBS
I received the following from Gerald on Sunday, 12/9, in response to two questions I asked (my questions are below his response):
Hello Victor,
We'll be updating the market through regulatory filings on these matters as they are completed. The CUSIP change/name change has already occurred and is being processed with our Transfer Agent, DTCC and FINRA as we speak. As for the state of incorporation, the lawyers are handling as well and we will update the market regarding all these matters when finished.
Best Regards,
Gerald
On Sun, Dec 9, 2012 at 9:17 AM, Victor Miller <vgmiller3@verizon.net> wrote:
Gerald,
Just a few questions:
1) From the 10-Q, "At a meeting held November 13th, 2012, the Board of Directors approved an increase in the authorized common shares of the corporation from 250,000,000 to 1,000,000,000. This increase was ratified by a written majority of voting of the common shares of the corporation in order to position the corporation for long-term growth. In conjunction with this decision, the Board and majority shareholders also approved relocating the Company’s state of incorporation from Delaware to Nevada primarily due to certain tax considerations for the corporation going forward."
Question: When do you anticipate the State of Incorporation change being completed?
2) Regarding the recent CUSIP # change...it appears this process has not yet been completed as numerous brokerages are still showing/using the old CUSIP shares.
Question: Is this all being done in conjunction with the State of Incorporation change? If so, do you have an anticipated timeline for its completion?
Regards,
Victor
The CUSIP change is still an ongoing process (see post 18449). I received this from Scottrade Monday (and verified this AM that it is still ongoing):
"Dear Victor:
In Dec. 2012, Amarantus Biosciences Inc (AMBS) declared a 1 for 1 CUSIP and name change on their outstanding shares. This was a mandatory corporate action that affected all shareholders.
A CUSIP is an identification number assigned to all stocks and registered bonds. The Committee on Uniform Securities Identification Procedures (CUSIP) oversees the entire CUSIP system. This system is used in the U.S. and Canada. Foreign securities have a similar number called the "CINS number". The new CUSIP will be 02300T109.
Although the company name and trading symbol will remain the same, this involves actually exchanging the old AMBS shares for new ones.
At this time we do not have an anticipated delivery date for the new shares. Scottrade will not post the new shares until we actually receive them from the company or their agent. Your patience is greatly appreciated.
Please let us know if you have any further questions and thank you for choosing Scottrade."
I would hate to be NSS when the CUSIP change is announced as completed and the cover begins, en masse.
Very, very long AMBS
pdpipeline.org not .com
The CUSIP change is still an ongoing process (see post 18449). I received this from Scottrade Monday (I just now confirmed that it is still ongoing.):
"Dear Victor:
In Dec. 2012, Amarantus Biosciences Inc (AMBS) declared a 1 for 1 CUSIP and name change on their outstanding shares. This was a mandatory corporate action that affected all shareholders.
A CUSIP is an identification number assigned to all stocks and registered bonds. The Committee on Uniform Securities Identification Procedures (CUSIP) oversees the entire CUSIP system. This system is used in the U.S. and Canada. Foreign securities have a similar number called the "CINS number". The new CUSIP will be 02300T109.
Although the company name and trading symbol will remain the same, this involves actually exchanging the old AMBS shares for new ones.
At this time we do not have an anticipated delivery date for the new shares. Scottrade will not post the new shares until we actually receive them from the company or their agent. Your patience is greatly appreciated.
Please let us know if you have any further questions and thank you for choosing Scottrade."
I would hate to be NSS when the CUSIP change is announced as completed and the cover begins, en masse.
Very, very long AMBS
I received the following from Gerald on Sunday, 12/9, in response to two questions I asked (my questions are below his response):
Hello Victor,
We'll be updating the market through regulatory filings on these matters as they are completed. The CUSIP change/name change has already occurred and is being processed with our Transfer Agent, DTCC and FINRA as we speak. As for the state of incorporation, the lawyers are handling as well and we will update the market regarding all these matters when finished.
Best Regards,
Gerald
On Sun, Dec 9, 2012 at 9:17 AM, Victor Miller <vgmiller3@verizon.net> wrote:
Gerald,
Just a few questions:
1) From the 10-Q, "At a meeting held November 13th, 2012, the Board of Directors approved an increase in the authorized common shares of the corporation from 250,000,000 to 1,000,000,000. This increase was ratified by a written majority of voting of the common shares of the corporation in order to position the corporation for long-term growth. In conjunction with this decision, the Board and majority shareholders also approved relocating the Company’s state of incorporation from Delaware to Nevada primarily due to certain tax considerations for the corporation going forward."
Question: When do you anticipate the State of Incorporation change being completed?
2) Regarding the recent CUSIP # change...it appears this process has not yet been completed as numerous brokerages are still showing/using the old CUSIP shares.
Question: Is this all being done in conjunction with the State of Incorporation change? If so, do you have an anticipated timeline for its completion?
Regards,
Victor
I received the following from Gerald on Sunday, 12/9, in response to two questions I asked (my questions are below his response):
Hello Victor,
We'll be updating the market through regulatory filings on these matters as they are completed. The CUSIP change/name change has already occurred and is being processed with our Transfer Agent, DTCC and FINRA as we speak. As for the state of incorporation, the lawyers are handling as well and we will update the market regarding all these matters when finished.
Best Regards,
Gerald
On Sun, Dec 9, 2012 at 9:17 AM, Victor Miller <vgmiller3@verizon.net> wrote:
Gerald,
Just a few questions:
1) From the 10-Q, "At a meeting held November 13th, 2012, the Board of Directors approved an increase in the authorized common shares of the corporation from 250,000,000 to 1,000,000,000. This increase was ratified by a written majority of voting of the common shares of the corporation in order to position the corporation for long-term growth. In conjunction with this decision, the Board and majority shareholders also approved relocating the Company’s state of incorporation from Delaware to Nevada primarily due to certain tax considerations for the corporation going forward."
Question: When do you anticipate the State of Incorporation change being completed?
2) Regarding the recent CUSIP # change...it appears this process has not yet been completed as numerous brokerages are still showing/using the old CUSIP shares.
Question: Is this all being done in conjunction with the State of Incorporation change? If so, do you have an anticipated timeline for its completion?
Regards,
Victor
The CUSIP change is still an ongoing process (see post 18449). I received this from Scottrade Monday:
"Dear Victor:
In Dec. 2012, Amarantus Biosciences Inc (AMBS) declared a 1 for 1 CUSIP and name change on their outstanding shares. This was a mandatory corporate action that affected all shareholders.
A CUSIP is an identification number assigned to all stocks and registered bonds. The Committee on Uniform Securities Identification Procedures (CUSIP) oversees the entire CUSIP system. This system is used in the U.S. and Canada. Foreign securities have a similar number called the "CINS number". The new CUSIP will be 02300T109.
Although the company name and trading symbol will remain the same, this involves actually exchanging the old AMBS shares for new ones.
At this time we do not have an anticipated delivery date for the new shares. Scottrade will not post the new shares until we actually receive them from the company or their agent. Your patience is greatly appreciated.
Please let us know if you have any further questions and thank you for choosing Scottrade."
I would hate to be NSS when the CUSIP change is announced as completed and the cover begins, en masse.
Very, very long AMBS
Seeking Alpha 12/9/12 blog:
http://seekingalpha.com/instablog/167303-jonathan-verenger/1348791-exciting-field-in-cure-for-parkinson-s
Very, very long AMBS
The CUSIP change is still an ongoing process (see post 18449). I received this from Scottrade yesterday:
"Dear Victor:
In Dec. 2012, Amarantus Biosciences Inc (AMBS) declared a 1 for 1 CUSIP and name change on their outstanding shares. This was a mandatory corporate action that affected all shareholders.
A CUSIP is an identification number assigned to all stocks and registered bonds. The Committee on Uniform Securities Identification Procedures (CUSIP) oversees the entire CUSIP system. This system is used in the U.S. and Canada. Foreign securities have a similar number called the "CINS number". The new CUSIP will be 02300T109.
Although the company name and trading symbol will remain the same, this involves actually exchanging the old AMBS shares for new ones.
At this time we do not have an anticipated delivery date for the new shares. Scottrade will not post the new shares until we actually receive them from the company or their agent. Your patience is greatly appreciated.
Please let us know if you have any further questions and thank you for choosing Scottrade."
I would hate to be NSS when the CUSIP change is announced as completed and the cover begins, en masse.
Very, very long AMBS
I received the following from Gerald on Sunday, 12/9, in response to two questions I asked (my questions are below his response):
Hello Victor,
We'll be updating the market through regulatory filings on these matters as they are completed. The CUSIP change/name change has already occurred and is being processed with our Transfer Agent, DTCC and FINRA as we speak. As for the state of incorporation, the lawyers are handling as well and we will update the market regarding all these matters when finished.
Best Regards,
Gerald
On Sun, Dec 9, 2012 at 9:17 AM, Victor Miller <vgmiller3@verizon.net> wrote:
Gerald,
Just a few questions:
1) From the 10-Q, "At a meeting held November 13th, 2012, the Board of Directors approved an increase in the authorized common shares of the corporation from 250,000,000 to 1,000,000,000. This increase was ratified by a written majority of voting of the common shares of the corporation in order to position the corporation for long-term growth. In conjunction with this decision, the Board and majority shareholders also approved relocating the Company’s state of incorporation from Delaware to Nevada primarily due to certain tax considerations for the corporation going forward."
Question: When do you anticipate the State of Incorporation change being completed?
2) Regarding the recent CUSIP # change...it appears this process has not yet been completed as numerous brokerages are still showing/using the old CUSIP shares.
Question: Is this all being done in conjunction with the State of Incorporation change? If so, do you have an anticipated timeline for its completion?
Regards,
Victor
Excellent news attesting to the commitment to transparency by the company. This is just the start to what I believe will be an amazing two weeks of news! 2013 will be AMBS' year.
Very, very long AMBS
Float as of 11/23/12 149,074,191 of unrestricted shares.
Perhaps a mod can update the i-box.
Very, very long AMBS
The CUSIP change is still an ongoing process (see post 18449). I received this from Scottrade today:
"Dear Victor:
In Dec. 2012, Amarantus Biosciences Inc (AMBS) declared a 1 for 1 CUSIP and name change on their outstanding shares. This was a mandatory corporate action that affected all shareholders.
A CUSIP is an identification number assigned to all stocks and registered bonds. The Committee on Uniform Securities Identification Procedures (CUSIP) oversees the entire CUSIP system. This system is used in the U.S. and Canada. Foreign securities have a similar number called the "CINS number". The new CUSIP will be 02300T109.
Although the company name and trading symbol will remain the same, this involves actually exchanging the old AMBS shares for new ones.
At this time we do not have an anticipated delivery date for the new shares. Scottrade will not post the new shares until we actually receive them from the company or their agent. Your patience is greatly appreciated.
Please let us know if you have any further questions and thank you for choosing Scottrade."
I would hate to be NSS when the CUSIP change is announced as completed and the cover begins, en masse.
Very, very long AMBS
I just received the following from Gerald in response to two questions I asked (my questions are below his response):
Hello Victor,
We'll be updating the market through regulatory filings on these matters as they are completed. The CUSIP change/name change has already occurred and is being processed with our Transfer Agent, DTCC and FINRA as we speak. As for the state of incorporation, the lawyers are handling as well and we will update the market regarding all these matters when finished.
Best Regards,
Gerald
On Sun, Dec 9, 2012 at 9:17 AM, Victor Miller <vgmiller3@verizon.net> wrote:
Gerald,
Just a few questions:
1) From the 10-Q, "At a meeting held November 13th, 2012, the Board of Directors approved an increase in the authorized common shares of the corporation from 250,000,000 to 1,000,000,000. This increase was ratified by a written majority of voting of the common shares of the corporation in order to position the corporation for long-term growth. In conjunction with this decision, the Board and majority shareholders also approved relocating the Company’s state of incorporation from Delaware to Nevada primarily due to certain tax considerations for the corporation going forward."
Question: When do you anticipate the State of Incorporation change being completed?
2) Regarding the recent CUSIP # change...it appears this process has not yet been completed as numerous brokerages are still showing/using the old CUSIP shares.
Question: Is this all being done in conjunction with the State of Incorporation change? If so, do you have an anticipated timeline for its completion?
Regards,
Victor
--
Gerald Commissiong
President & CEO
Amarantus BioSciences, Inc.
C/O The Parkinson's Institute
675 Almanor Ave.
Sunnyvale, CA 94085
gerald@amarantus.com
www.amarantus.com
Ph: 408-737-2734
Fax: 408-852-4427
Empire is no longer TA (as noted in my post 15266). VStock Transfer, LLC, is, and here is info from a previous post (15283) where I contacted VStock:
"Mr. Miller
I am sorry, but we do not provide public disclosure of information on behalf of our clients.
Yoel Goldfeder, Esq.
Chief Executive Officer
VStock Transfer, LLC
77 Spruce Street, Suite 201
Cedarhurst, New York 11516
Phone: (212) 828-8436
Mobile: (646) 599-1296
Facsimile: (646) 536-3179
www.VStockTransfer.com"
I would be interested in hearing thoughts on possible ways (custody-only trading, reverse split, etc.) to combat the NSS issue AMBS seems to have.
Very, very long AMBS
Now here is what I would call a "coincidence":
At 12:05 you post about that Exclusive Stocks alert with AMBS sitting about .0326. Within minutes, volume spikes and the price immediately starts dropping and dips to "exactly" the range they cite in their alert. Hmmmm.
Notice which MM was mostly involved...PERT!
This incites others to sell and other MMs to "play."
I will be watching for this in the future, now that I've seen the mechanism in action.
Very, very long AMBS
Potential multi-billion dollar company in the making:
1) First test ever for Parkinsonism.
2) First test ever for Alzheimers disease.
3) Possible drug to cure Parkinsonism.
4) Drug to HEAL heart damage maybe up to 40% in heart attack victims.
5) Possible drug to heal stroke victims.
6) Dr. Joseph Rubinfeld, Amgen Co Founder states, "I believe in MANF. I have reviewed a great number of technologies in my 45 year career in the biopharmaceutical field, and I believe that MANF could be one of the biggest successes that I have ever seen. The fundamental scientific premise of reducing protein misfolding is basic, yet very profound. The data, while early, demonstrates very clearly at the cellular level and in animals that MANF reduces apoptosis, improves cellular function, and restores behavioural deficits in a number of disease models, including Parkinson's, Stroke, Myocardial Infarction and Traumatic Brain Injury. These are all indications with very large markets and clear unmet medical need. I believe that if we are able to further de-risk MANF with positive toxicology studies and early clinical data, the Company's new orphan drug strategy could get MANF to market rather expeditiously. MANF has the commercial potential to become a blockbuster drug."
Very, very long AMBS